Evidence map›Paper›PMID 38250091›Full record

ArticleClinical case reports2024

Symptomatic creatine phosphokinase elevation in a Crohn's disease patient caused by upadacitinib.

Anna Schuitema, Suzanne I Anjie, Agnies M van Eeghen, Sander W Tas, Mark Löwenberg

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical case reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 2 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Anna SchuitemaDepartment of Gastroenterology and Hepatology Amsterdam UMC, Location Academic Medical Center, University of Amsterdam Amsterdam The Netherlands.ORCID https://orcid.org/0009-0008-1303-9971
Suzanne I AnjieDepartment of Gastroenterology and Hepatology Amsterdam UMC, Location Academic Medical Center, University of Amsterdam Amsterdam The Netherlands.
Agnies M van Eeghen's Heeren Loo Amersfoort The Netherlands.
Sander W TasDepartment of Rheumatology Amsterdam UMC, Location Academic Medical Center, University of Amsterdam Amsterdam The Netherlands.
Mark LöwenbergDepartment of Gastroenterology and Hepatology Amsterdam UMC, Location Academic Medical Center, University of Amsterdam Amsterdam The Netherlands.
Amsterdam UMC Location University of Amsterdam · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We present a Crohn's disease patient receiving high dose upadacitinib treatment with elevated CPK levels and myopathy, and provide the reader with practical tips on stopping and restarting upadacitinib, emphasizing the need for adequate monitoring.

Indexed as

CPK elevationCrohn's diseasemyopathyupadacitinib

Identifiers

PMID38250091
PMCPMC10799215
OpenAlexW4391053906

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.